Ramtin Agah - Aug 30, 2021 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director, 10%+ Owner
Signature
/s/ Ramtin Agah MD
Stock symbol
RNXT
Transactions as of
Aug 30, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 04:06 PM
Previous filing
Jun 17, 2022
Next filing
Oct 4, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Conversion of derivative security +1.3K +0.13% 976K Aug 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Convertible Notes Conversion of derivative security $0 -1.3K -100% $0.00* 0 Aug 30, 2021 Common Stock 1.3K Direct F1
transaction RNXT Warrants (right to buy) Conversion of derivative security $0 +1.3K $0.00 1.3K Aug 30, 2021 Common Stock 1.3K $10.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.
F2 The shares of Common Stock underlying the warrant are immediately exercisable.